Women’s Health Week Europe 2026 has released its full programme ahead of the October event at The Emirates Stadium in London on 7–8 October, with 700+ senior decision-makers and 80+ speakers confirmed across what will be the organisation’s most ambitious edition to date.

For the first time, the event will run across two dedicated stages, each built around a distinct set of questions facing the women’s health industry.

The Global Stage takes on the macro forces shaping the sector: where capital is flowing, how AI is transforming diagnosis and treatment, the gender data gap, wearable technology, stigmatised markets, and the policy landscape across Europe.

Confirmed speakers include Merete Clausen (EIF), Frida Polli (MIT), Nichole Young-Lin (Google), Alison Cave (MHRA), Emily Darlington MP, Kerry Buckley (Boots), Tim Davis (LSEG), Henriette Hessen (Verdane), Hillary Ball (Atomico), and Christine Hockley (British Business Bank).

The Scale Stage runs in parallel, focused on execution: how to navigate regulatory approval pathways, survive the valley of death, build the evidence stack that wins payers and partners, implement AI into a women’s health business, and position for acquisition. Sessions include a reverse pitch format, in which corporates and investors pitch to founders, and a founder’s guide to getting acquired.

The programme also includes two Pitch competitions, one per day, across the Consumer & Tech and Medical Devices & Therapeutics categories, with 16 finalists competing on the mainstage in front of the full delegate audience.

Every session is case study-driven, with speakers selected on the basis of having lived the problem they are on stage to solve.

Women’s Health Week Europe 2026 takes place 7–8 October at The Emirates Stadium, London. The full programme is available now.

View the 2026 programme here

Pre-agenda pricing ends 26 June

Tickets are currently available at pre-agenda pricing, with savings of up to £600 off standard pricing. The deadline is midnight on Friday 26 June. After that, prices go up.

Secure your place: https://wplatform.co/summits/womens-health-week-europe-2026?utm_source=advocacy&utm_medium=ext_email&utm_campaign=whw-europe-26-femtech-world#tickets

Also at The Emirates: Women’s Sport Summit 2026

The day before WHW Europe, on 6 October, The Emirates Stadium will also host the inaugural Women’s Sport Summit, a dedicated one-day event bringing together 400+ attendees from across sport, business, and investment. Focused on the commercial side of women’s sport, the Summit covers the full sports cycle: money, product, and market. Where women’s sport means business.

Find out more: https://wplatform.co/summits/womens-sport-summit-europe-2026?utm_source=advocacy&utm_medium=ext_email&utm_campaign=whw-europe-26-femtech-world

A sold-out summit at the London Institute for Healthcare Engineering will bring together clinicians, researchers, regulators, investors and founders to discuss how artificial intelligence is being applied to women’s health, and what responsible development of these tools should look like.

AI × Women’s Health: Innovation, Challenges and Opportunities takes place on 25 June.

It’s organised by MEGI Health, a femtech company building a digital cardiovascular platform aimed at supporting women’s heart health through pregnancy, postpartum and beyond.

All 140 places have gone, and there’s now a waiting list.

Nina Sesto, CEO of MEGI Health, said: “We are seeing a wave of innovation in women’s health, and AI has the potential to accelerate it.

“The opportunity is enormous, but it only pays off if these tools are built on representative data and designed around the realities of women’s health.

“That is exactly the conversation we wanted to convene, across clinicians, researchers, industry and regulators.”

AI is increasingly being applied across women’s healthcare, with proponents pointing to earlier diagnosis, better risk prediction and more personalised care.

The summit will look at tools in development across fetal and gynaecological ultrasound, maternal cardiovascular monitoring and clinical decision support, alongside the question of whether women risk being left behind as the technology develops.

The timing reflects wider momentum in the sector: women’s health has been drawing more investment and policy attention, and the World Economic Forum and McKinsey Health Institute have estimated that closing the women’s health gap could add at least $1 trillion a year to the global economy by 2040.

A recurring theme for the day is data.

Women have historically been under-represented in medical research, and organisers argue that AI tools trained on incomplete or unrepresentative datasets risk repeating those gaps rather than closing them.

Sessions on data, ethics, privacy and equity will run alongside the more technical and commercial discussions.

Dr Fran Conti-Ramsden is a clinician at Guy’s and St Thomas’ NHS Foundation Trust, academic at King’s College London and Chief Medical Officer of MEGI Health.

Conti-Ramsden said: “Working at the intersection of clinical practice, academia and industry, I see both the tremendous challenges we face in delivering clinical care for women and the need for innovation, alongside the rapid development of AI and digital health technologies.

“But bringing innovation into clinical practice is fraught with challenges.

“I hope this day brings together people from across the landscape to discuss and define those challenges as well as celebrate progress in the field, sparking dialogue on how we should innovate responsibly, and to make sure women’s health is not left behind.”

The half-day programme is split into four sessions, chaired respectively by Professor Eugene Oteng-Ntim, Professor Richard Dobson, an interactive breakout segment, and Professor Asma Khalil. Other speakers include MiRa Jacobs (MHRA), Professor Jane Hirst (The George Institute), Tulsi Patel (Hertility) and Dr Kimberley Peven (Scarlet), among others.

Organisers say they hope the event will help build a longer-term UK community around clinical AI in women’s health.

Senior executives from the World Economic Forum, Takeda and Gilead are among the latest speakers confirmed for Women’s HealthX, which takes place on 3–4 December 2026 in Boston, Massachusetts, as the event publishes its full agenda.

The newly announced speakers are Melissa Patel, lead for women’s health responsible investing at the World Economic Forum; Nicola Greenway, chief human resources officer at Takeda; and Jyoti Mehra, executive vice president of human resources at Gilead.

They join more than 75 confirmed speakers and a delegate list the organisers say will exceed 750 leaders from pharma and biotech, hospitals and health systems, payers and policymakers, all focused on closing the sex-difference data gap in healthcare.

Organisations registered to attend span much of the sector.

In pharma and biotech they include Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly, Bayer, Biogen, Johnson & Johnson, Gilead Sciences, Takeda, UCB, Astellas, EMD Serono, Amgen, Bristol Myers Squibb, Boehringer Ingelheim and Chiesi.

Among hospitals, health systems and academic medical centres are Mayo Clinic, Mass General Brigham, Northwell Health, UPMC, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Weill Cornell Medicine, Massachusetts General Hospital, Northwestern Medicine, Mount Sinai Health System, UMass Memorial Medical Center, Tufts Medical Center, Yale School of Medicine, Harvard Medical School, Columbia University Irving Medical Center, University of Pennsylvania Health System and NYU Langone Health.

Payers and health plans represented include CVS Health, Humana, Cigna Healthcare, Kaiser Permanente, Elevance Health, Blue Cross Blue Shield of Tennessee, Blue Cross Blue Shield of Massachusetts, Evernorth, Fidelis Care, Health Plans Inc and UPMC Health Plan.

On the government, policy and regulatory side, attendees include the U.S. Department of Veterans Affairs, ARPA-H, the FDA, HHS, the NYC Department of Health and Mental Hygiene, Metro Public Health Department, the Association of State and Territorial Health Officials, the NHS, the Northern Mariana Islands Board of Nursing and Planned Parenthood of Florida.

A sample attendee list is available here.

Newly confirmed panels

Patel will join Sheri Schully, deputy chief medical and scientific officer at the All of Us Research Program, and Lindsey Miltenberger, chief advocacy officer at the Society for Women’s Health Research, for a panel titled “Driving Inclusive Health Research on a Global Scale: Using Data to Understand National Priorities and Address Critical Gaps in Women’s Health.”

The session will look at the health priorities countries are focusing on today and how data can be used to identify gaps in women’s health that remain overlooked.

Greenway and Mehra will take part in a panel titled “Empowering Workforces Through Women’s Health,” in which corporate health leaders discuss women’s health priorities from both employee and employer perspectives, and which benefits organisations should be prioritising.

The full agenda is now available, and registration is open.